The placebo phenomenon and medical ethics: Rethinking the relationship between informed consent and risk–benefit assessment

Theoretical Medicine and Bioethics 32 (4):229-243 (2011)

Abstract

It has been presumed within bioethics that the benefits and risks of treatments can be assessed independently of information disclosure to patients as part of the informed consent process. Research on placebo and nocebo effects indicates that this is not true for symptomatic treatments. The benefits and risks that patients experience from symptomatic treatments can be shaped powerfully by information about these treatments provided by clinicians. In this paper we discuss the implications of placebo and nocebo research for risk–benefit assessment and informed consent

Download options

PhilArchive



    Upload a copy of this work     Papers currently archived: 72,766

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2012-08-28

Downloads
188 (#64,402)

6 months
1 (#386,989)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Franklin Miller
Columbia University

Similar books and articles

The Nocebo Effect of Informed Consent.Shlomo Cohen - 2014 - Bioethics 28 (3):147-154.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
Rethinking Informed Consent in Bioethics.Neil C. Manson - 2007 - Cambridge University Press.
Semiotics and the Placebo Effect.Franklin G. Miller & Luana Colloca - 2010 - Perspectives in Biology and Medicine 53 (4):509-516.
A Limited Defense of Clinical Placebo Deception.Adam J. Kolber - 2007 - Yale Law & Policy Review 26:75-134.